| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NAN.12231 |
| P698 | PubMed publication ID | 25711697 |
| P50 | author | Frank L. Heppner | Q56955724 |
| Francois Jerome Authier | Q70896551 | ||
| Yves Allenbach | Q82626300 | ||
| P2093 | author name string | Romain Gherardi | |
| Werner Stenzel | |||
| Matthias Vorgerd | |||
| Rudolf A Kley | |||
| Corinna Preusse | |||
| Jan L Rinnenthal | |||
| Debora Pehl | |||
| Hans-H Goebel | |||
| P2860 | cites work | DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features | Q24672682 |
| Foreign body-type multinucleated giant cell formation is potently induced by alpha-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022 | Q24685285 | ||
| Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice | Q28207641 | ||
| The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis | Q31928108 | ||
| Central nervous system disease in patients with macrophagic myofasciitis | Q33945361 | ||
| Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM). | Q34067293 | ||
| Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle | Q34088179 | ||
| M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis | Q34756244 | ||
| Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells | Q34764301 | ||
| Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. | Q35083498 | ||
| Towards an understanding of the adjuvant action of aluminium | Q35138579 | ||
| Increased interleukin-13 expression in patients with sarcoidosis | Q35535981 | ||
| Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells | Q35563269 | ||
| Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages | Q35825861 | ||
| Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. | Q35916038 | ||
| Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
| Slow CCL2-dependent translocation of biopersistent particles from muscle to brain | Q36741197 | ||
| Essential role of DAP12 signaling in macrophage programming into a fusion-competent state | Q37171072 | ||
| Hypothesis: sarcoidosis is a STAT1-mediated disease | Q37323719 | ||
| Molecular mediators of macrophage fusion | Q37592510 | ||
| Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease | Q37794845 | ||
| Transcriptional regulation of macrophage polarization: enabling diversity with identity | Q37949245 | ||
| Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile | Q39537966 | ||
| Cellular networks controlling Th2 polarization in allergy and immunity | Q42008855 | ||
| Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum | Q46657854 | ||
| Macrophagic myofasciitis and vaccination: consequence or coincidence? | Q51134671 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 952-963 | |
| P577 | publication date | 2015-05-19 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis | |
| P478 | volume | 41 |
Search more.